Allergic contact blepharoconjunctivitis from dorzolamide.
Mancuso
G
G
Department of Dermatology, Municipal Hospital of Lugo, Ravenna, Italy.
Berdondini
R M
RM
D000368:Aged; D001762:Blepharitis / Q000139:chemically induced*; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003233:Conjunctivitis, Allergic / Q000139:chemically induced*; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D008297:Male; D009883:Ophthalmic Solutions / Q000009:adverse effects* / Q000627:therapeutic use; D010328:Patch Tests; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use
D002257:Carbonic Anhydrase Inhibitors; D009883:Ophthalmic Solutions; D013449:Sulfonamides; D013876:Thiophenes; C062765:dorzolamide